Abstract
Humphrey has spent about equal time as a pathologist and as a biologist, and about equal time in academia and industry. He has run clinical and anatomical pathology labs including knockout service facilities for mice, histomorphology laboratories doing immunohistochemistry (IHC) and immunofluorescence (IF) with image analysis, and CAP/CLA-approved laboratories doing IHC for oncology clinical trials. What follows is a collection of his observations of potential misunderstandings between scientists and pathologists that can arise in the analysis of tissue for clinical trials, with a particular emphasis on oncology.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tabernero J, Rojo F, Calvo E, Burris H, Judson I, Hazell K, Martinelli E, Ramon y Cajal S, Jones S, Vidal L, Shand N, Macarulla T, Ramos FJ, Dimitrijevic S, Zoellner U, Tang P, Stumm M, Lane HA, Lebwohl D, Baselga J. Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors. J Clin Oncol. 2008;26(10):1603–1610. doi: 10.1200/JCO.2007.14.5482. Epub 2008 Mar 10
van Netten JP, Thornton IG, Carlyle SJ, Brigden ML, Coy P, Goodchild NL, Gallagher S, George EJ (1987) Multiple microsample analysis of intratumor estrogen receptor distribution in breast cancers by a combined biochemical/immunohistochemical method. Eur J Cancer Clin Oncol 23(9):1337–1342
Katz RL, He W, Khanna A, Fernandez RL, Zaidi TM, Krebs M, Caraway NP, Zhang HZ, Jiang F, Spitz MR, Blowers DP, Jimenez CA, Mehran RJ, Swisher SG, Roth JA, Morris JS, Etzel CJ, El-Zein R (2010) Genetically abnormal circulating cells in lung cancerpatients: an antigen-independent fluorescence in situ hybridization-based case-control study. Clin Cancer Res 16:3976–3987
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Gardner, H. (2014). A Field Guide to Homo morphologicus for Biomedical Scientists, Or How to Convey an Understanding of Pathology to Scientists in a Biopharma Enterprise. In: Potts, S., Eberhard, D., Wharton, Jr., K. (eds) Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development. Methods in Pharmacology and Toxicology. Humana Press, New York, NY. https://doi.org/10.1007/7653_2014_16
Download citation
DOI: https://doi.org/10.1007/7653_2014_16
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2680-0
Online ISBN: 978-1-4939-2681-7
eBook Packages: Springer Protocols